Smart resources for start-ups in Manitoba’s capital
News & Media
After being away for over two decades, Ms. Hanham is coming home – not because the venture capital business in Canada is thriving, but because it isn’t. And she wants to change that.
Join more than 600 business leaders from more than 40 world economic regions.
The U of W along with partners in Prairie Isotope Production Enterprise are optimistic that Tc-99m can be produced on a commercial scale, providing a Made-in-Manitoba solution to local and regional future medical isotope needs. PIPE is a non-profit consor
Entrepreneurs will have the chance to learn new techniques and improve their selling skills at the Capturing Opportunities 2012 rural business forum by participating in the Entrepreneur Boot Camp, Agriculture, Food and Rural Initiatives Minister Ron Kosty
Congratulations to DiaMedica for being named as one of the TSX Venture Top 50 ® companies for 2012.
PreVu® Non-Invasive Skin Cholesterol Point of Care Test has been cleared for sale by Health Canada
Scientists at CCARM were looking to attract attention to their display on the potential health benefits of pulse crops
Expands Enrollment with Addition of Trial Site in India
The Manitoba Knights is a group that was formed in the fall, loosely connected to Biomedical Commercialization Canada
Manitoba could be a petri dish for health-care innovations that could save the government $500 million a year.
On Wednesday afternoon, five Winnipeg technology companies showed off the scope of innovation and enterprise that exists in Winnipeg. The fact most of them need additional capital and other strategic assistance to survive does not detract from the exce
A class II medical device license application was filed for the Non-Invasive Skin Cholesterol Point of Care test
$400,000 in grants provide financial incentive to use biomass.
Thanks to combined investments of $1.2 million from the Governments of Canada and of Manitoba business leaders from around the world will have an opportunity to participate in Centralia 2012.
Congratulations to Conviron for winning Manitoba's Exporter of the Year and Intelligent Hospital Systems for winning the CME's Emerging award.
Centrallia 2012 is what we're calling speed-dating for business. We want to hook you up and help you build new relationships, so your business prospers.
DiaMedica announced the successful humanization of its monoclonal antibody DM-204 for Type 2 diabetes and diabetic related complications of hypertension and cholesterol.
Intelligent Hospital Systems is building its order book for its million-dollar robotic pharmaceutical dispensers
Intelligent Hospital Systems has announced the release of a new enhanced version of Robotic Intravenous Automation.
DiaMedica's DM-199 for Type 1 Diabetes significantly delays autoimmune attack and demonstrates a dramatic increase in C-Peptide levels
DiaMedica reported that chronic administration of DM-199 significantly delayed the autoimmune attack, preserved beta cell mass and demonstrated a 12-fold increase in circulating C-peptide levels in an in vivo study.